Friday Pop Quiz #289
The correct answer is C. Continue guselkumab, start topical steroids and low-dose methotrexate.
Combination therapy with MTX and biologics may serve as an efficacious treatment for psoriasis patients with an inadequate response to DMARD monotherapy. Adjuvant topical therapy and low-dose methotrexate to guselkumab may help preserve duration of her response to guselkumab.
The patient’s u …
During the 2024 Pigmentary Disorders Exchange Symposium, expert dermatologists discussed and shed light on the evolving therapeutic landscape of pigmentary disorders. They addressed key advances, challenges, and gaps in current knowledge. The panel, which was moderated by Dr. Pearl Grimes, featured Dr. John Harris, Dr. Thierry Passeron, and Dr. Ariel Kauvar.
Dr. Harris kicked off the panel disc …
Dermatologic procedures in children can be stressful for the patient, parent and the clinician. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Watch as Dr. Kirkorian shares four hot tips for procedures in kids. Find out why you might want to reconsider some …
In the August edition of the Journal of Drugs in Dermatology (JDD), we turn our focus to psoriasis, one of the most challenging and impactful dermatological conditions. This month’s Editor's Picks showcase a series of in-depth studies and expert discussions that explore the latest advancements in psoriasis treatment, real-world effectiveness, and the broader implications of the disease …